In response to rising medical demand and the public health emergency brought on by the COVID-19 epidemic, research efforts have ramped up, testing has increased, and factories are getting ready to manufacture the vaccines currently being developed. Stäubli is rising to the challenge to meet the specific needs of each of the sectors concerned.
Our Patient Care solutions help our customers work faster and with greater precision, whether in developing, producing, and packaging medications or operating on and caring for patients.
For example, in research labs and analysis labs, robots can handle samples more safely and faster.
“Stäubli has received many rush orders for products used in the fight against COVID-19, especially in France, U.S.A. and China”
Sébastien Lagarde, Global Business Developer Life Sciences, Stäubli
Stäubli robots are used in the manufacturing of medical devices and orthopedic implants to polish implant surfaces, including the injection molding of plastic medical components.
In the pharmaceutical and biotechnology industry, Stäubli robots help prepare drugs manufacturing and fill syringes vials as well as infusion bags. Fully encapsulated kinematics meet strict clean room hygiene standards. The Stericlean line of robots features an H₂O₂-compatible surface. The world’s first Stericlean SCARA came on the market in 2019.
Stäubli robots can also be found in:
For thirty years, Stäubli Robotics has worked to ensure that precision and cleanability are the norm in healthcare and life sciences settings.
For spinal surgery knee surgery, liver surgery and dental repair, Stäubli solutions have a dual positive impact:
For patients, robot-assisted surgery is less invasive which shortens recovery time.
For surgeons, robots enhance operative precision, improving outcomes without replacing them in their role.
The challenge facing robotics is to integrate robotic arms in the operating room and resolve sterilization concerns. In terms of usability, the robot shouldn’t hinder the medical team. It should give surgeons the feeling that they’re operating by hand.Sébastien Lagarde, Global Business Developer Life Sciences, Stäubli